Adenylosuccinate Lyase Deficiency (disorder)

Overview of Adenylosuccinate Lyase Deficiency (disorder)

Most recent studies have shown that Adenylosuccinate Lyase Deficiency (disorder) shares some biological mechanisms with atrophy, autistic-disorder, brain-diseases-metabolic-inborn, convulsion-neonatal, developmental-delay-(disorder), dihydropyrimidine-dehydrogenase-deficiency, encephalopathies, encephalopathy-neonatal, epilepsy, growth-retardation, inborn-errors-of-metabolism, metabolic-diseases, microcephaly, muscle-hypotonia, nervous-system-disorder, psychomotor-disorders, purine-metabolism-disorder.

Among the many pathways, these few ones have gauged particular interests from scientists studying Adenylosuccinate Lyase Deficiency (disorder), and have been seen in publications frequently: Excretion, Localization, Myelination, Pathogenesis, Reflex, Regeneration, Transport, Urea Cycle

Quite a number of genes have been found to play important roles in Adenylosuccinate Lyase Deficiency (disorder), such as ABAT, ACE, ADSL, ASL, ATIC, BRAP, CSF2, DPYD, IMPA1, LAMC2, MTSS1, NT5E, OTC, PNP, RBKS, TXN. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.

In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.

Adenylosuccinate Lyase Deficiency (disorder) Related Genes

click to see detail information for each gene

Pathways Related to Adenylosuccinate Lyase Deficiency (disorder)

This information is being compiled and will come in a future update

Related Diseases